RNA Based Therapeutics Market Report

Global and Region RNA Based Therapeutics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：160
  • REPORT CODE：GMM988263
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of RNA Based Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of RNA Based Therapeuticsmarket, defines the market attractiveness level of RNA Based Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of RNA Based Therapeutics industry, describes the types of RNA Based Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global RNA Based Therapeutics market and the development prospects and opportunities of RNA Based Therapeutics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global RNA Based Therapeutics market in Chapter 13.

    By Player:

    • Quark Pharmaceuticals (USA)

    • Dicerna Pharmaceuticals (USA)

    • Silence Therapeutics PLC (UK)

    • ISIS pharmaceuticals (USA)

    • Alnylam Pharmaceuticals (USA)

    • Tekmira Pharmaceuticals Corp (Canada)

    • Benitec Biopharma Limited (Australia)

    • Genzyme Corporation (USA)

    • Cenix BioScience GmbH (Germany)

    By Type:

    • qRT-PCR

    • RNA Interference (RNAi) Technologies

    • RNA Antisense

    • Inhibition

    • Microarrays

    • Labeling

    • Purification

    By End-User:

    • Cardiovascular

    • Kidney Diseases

    • Oncology

    • Infectious Diseases

    • Metabolic Disorders

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 RNA Based Therapeutics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 RNA Based Therapeutics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 RNA Based Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 RNA Based Therapeutics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise RNA Based Therapeutics Market Analysis and Outlook to 2022

    • 7.1 Global RNA Based Therapeutics Consumption (2017-2022)

    • 7.2 United States RNA Based Therapeutics Consumption (2017-2022)

    • 7.3 Europe RNA Based Therapeutics Consumption (2017-2022)

    • 7.4 China RNA Based Therapeutics Consumption (2017-2022)

    • 7.5 Japan RNA Based Therapeutics Consumption (2017-2022)

    • 7.6 India RNA Based Therapeutics Consumption (2017-2022)

    • 7.7 South Korea RNA Based Therapeutics Consumption (2017-2022)

    8 Region and Country-wise RNA Based Therapeutics Market Analysis and Outlook to 2028

    • 8.1 Global RNA Based Therapeutics Consumption Forecast (2022-2028)

    • 8.2 United States RNA Based Therapeutics Consumption Forecast (2022-2028)

    • 8.3 Europe RNA Based Therapeutics Consumption Forecast (2022-2028)

    • 8.4 China RNA Based Therapeutics Consumption Forecast (2022-2028)

    • 8.5 Japan RNA Based Therapeutics Consumption Forecast (2022-2028)

    • 8.6 India RNA Based Therapeutics Consumption Forecast (2022-2028)

    • 8.7 South Korea RNA Based Therapeutics Consumption Forecast (2022-2028)

    9 Global RNA Based Therapeutics Market Outlook by Types and Applications to 2022

    • 9.1 Global RNA Based Therapeutics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global qRT-PCR Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global RNA Interference (RNAi) Technologies Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global RNA Antisense Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Inhibition Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Microarrays Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Labeling Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Purification Consumption and Growth Rate (2017-2022)

    • 9.2 Global RNA Based Therapeutics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Cardiovascular Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Kidney Diseases Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Oncology Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Infectious Diseases Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Metabolic Disorders Consumption and Growth Rate (2017-2022)

    10 Global RNA Based Therapeutics Market Outlook by Types and Applications to 2028

    • 10.1 Global RNA Based Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global qRT-PCR Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global RNA Interference (RNAi) Technologies Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global RNA Antisense Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Inhibition Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Microarrays Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Labeling Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.7 Global Purification Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global RNA Based Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Cardiovascular Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Kidney Diseases Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Oncology Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Infectious Diseases Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Metabolic Disorders Consumption Forecast and Growth Rate (2022-2028)

    11 Global RNA Based Therapeutics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global RNA Based Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global RNA Based Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 RNA Based Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global RNA Based Therapeutics Market Competitive Analysis

    • 14.1 Quark Pharmaceuticals (USA)

      • 14.1.1 Quark Pharmaceuticals (USA) Company Details

      • 14.1.2 Quark Pharmaceuticals (USA) RNA Based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Quark Pharmaceuticals (USA) RNA Based Therapeutics Product and Service

    • 14.2 Dicerna Pharmaceuticals (USA)

      • 14.2.1 Dicerna Pharmaceuticals (USA) Company Details

      • 14.2.2 Dicerna Pharmaceuticals (USA) RNA Based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Dicerna Pharmaceuticals (USA) RNA Based Therapeutics Product and Service

    • 14.3 Silence Therapeutics PLC (UK)

      • 14.3.1 Silence Therapeutics PLC (UK) Company Details

      • 14.3.2 Silence Therapeutics PLC (UK) RNA Based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Silence Therapeutics PLC (UK) RNA Based Therapeutics Product and Service

    • 14.4 ISIS pharmaceuticals (USA)

      • 14.4.1 ISIS pharmaceuticals (USA) Company Details

      • 14.4.2 ISIS pharmaceuticals (USA) RNA Based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 ISIS pharmaceuticals (USA) RNA Based Therapeutics Product and Service

    • 14.5 Alnylam Pharmaceuticals (USA)

      • 14.5.1 Alnylam Pharmaceuticals (USA) Company Details

      • 14.5.2 Alnylam Pharmaceuticals (USA) RNA Based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Alnylam Pharmaceuticals (USA) RNA Based Therapeutics Product and Service

    • 14.6 Tekmira Pharmaceuticals Corp (Canada)

      • 14.6.1 Tekmira Pharmaceuticals Corp (Canada) Company Details

      • 14.6.2 Tekmira Pharmaceuticals Corp (Canada) RNA Based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Tekmira Pharmaceuticals Corp (Canada) RNA Based Therapeutics Product and Service

    • 14.7 Benitec Biopharma Limited (Australia)

      • 14.7.1 Benitec Biopharma Limited (Australia) Company Details

      • 14.7.2 Benitec Biopharma Limited (Australia) RNA Based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Benitec Biopharma Limited (Australia) RNA Based Therapeutics Product and Service

    • 14.8 Genzyme Corporation (USA)

      • 14.8.1 Genzyme Corporation (USA) Company Details

      • 14.8.2 Genzyme Corporation (USA) RNA Based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Genzyme Corporation (USA) RNA Based Therapeutics Product and Service

    • 14.9 Cenix BioScience GmbH (Germany)

      • 14.9.1 Cenix BioScience GmbH (Germany) Company Details

      • 14.9.2 Cenix BioScience GmbH (Germany) RNA Based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Cenix BioScience GmbH (Germany) RNA Based Therapeutics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of RNA Based Therapeutics

    • Figure RNA Based Therapeutics Picture

    • Table Global RNA Based Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global RNA Based Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global RNA Based Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global RNA Based Therapeutics Consumption by Country (2017-2022)

    • Figure United States RNA Based Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Europe RNA Based Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure China RNA Based Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Japan RNA Based Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure India RNA Based Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure South Korea RNA Based Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Global RNA Based Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure United States RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea RNA Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global qRT-PCR Consumption and Growth Rate (2017-2022)

    • Figure Global RNA Interference (RNAi) Technologies Consumption and Growth Rate (2017-2022)

    • Figure Global RNA Antisense Consumption and Growth Rate (2017-2022)

    • Figure Global Inhibition Consumption and Growth Rate (2017-2022)

    • Figure Global Microarrays Consumption and Growth Rate (2017-2022)

    • Figure Global Labeling Consumption and Growth Rate (2017-2022)

    • Figure Global Purification Consumption and Growth Rate (2017-2022)

    • Figure Global Cardiovascular Consumption and Growth Rate (2017-2022)

    • Figure Global Kidney Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Oncology Consumption and Growth Rate (2017-2022)

    • Figure Global Infectious Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Metabolic Disorders Consumption and Growth Rate (2017-2022)

    • Figure Global qRT-PCR Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global RNA Interference (RNAi) Technologies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global RNA Antisense Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Inhibition Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Microarrays Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Labeling Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Purification Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cardiovascular Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Kidney Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Infectious Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Metabolic Disorders Consumption Forecast and Growth Rate (2022-2028)

    • Table Global RNA Based Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global RNA Based Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    • Table Quark Pharmaceuticals (USA) (Foundation Year, Company Profile and etc.)

    • Table Quark Pharmaceuticals (USA) RNA Based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Quark Pharmaceuticals (USA) RNA Based Therapeutics Product and Service

    • Table Dicerna Pharmaceuticals (USA) (Foundation Year, Company Profile and etc.)

    • Table Dicerna Pharmaceuticals (USA) RNA Based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dicerna Pharmaceuticals (USA) RNA Based Therapeutics Product and Service

    • Table Silence Therapeutics PLC (UK) (Foundation Year, Company Profile and etc.)

    • Table Silence Therapeutics PLC (UK) RNA Based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Silence Therapeutics PLC (UK) RNA Based Therapeutics Product and Service

    • Table ISIS pharmaceuticals (USA) (Foundation Year, Company Profile and etc.)

    • Table ISIS pharmaceuticals (USA) RNA Based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table ISIS pharmaceuticals (USA) RNA Based Therapeutics Product and Service

    • Table Alnylam Pharmaceuticals (USA) (Foundation Year, Company Profile and etc.)

    • Table Alnylam Pharmaceuticals (USA) RNA Based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alnylam Pharmaceuticals (USA) RNA Based Therapeutics Product and Service

    • Table Tekmira Pharmaceuticals Corp (Canada) (Foundation Year, Company Profile and etc.)

    • Table Tekmira Pharmaceuticals Corp (Canada) RNA Based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tekmira Pharmaceuticals Corp (Canada) RNA Based Therapeutics Product and Service

    • Table Benitec Biopharma Limited (Australia) (Foundation Year, Company Profile and etc.)

    • Table Benitec Biopharma Limited (Australia) RNA Based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Benitec Biopharma Limited (Australia) RNA Based Therapeutics Product and Service

    • Table Genzyme Corporation (USA) (Foundation Year, Company Profile and etc.)

    • Table Genzyme Corporation (USA) RNA Based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genzyme Corporation (USA) RNA Based Therapeutics Product and Service

    • Table Cenix BioScience GmbH (Germany) (Foundation Year, Company Profile and etc.)

    • Table Cenix BioScience GmbH (Germany) RNA Based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cenix BioScience GmbH (Germany) RNA Based Therapeutics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US